Gulf War Illness, Clinical Trial Award
The summary for the Gulf War Illness, Clinical Trial Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
Gulf War Illness, Clinical Trial Award: The FY18 GWIRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on GWI. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Health outcomes of interest should include improvements in overall functional status or in symptom complexes (e.g., cognitive function, musculoskeletal/pain symptoms, gastrointestinal symptoms, fatigue, respiratory problems, skin abnormalities, sleep difficulties, and others). Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in GWI Veteran populations. For applications proposing initial evaluation of a treatment or intervention in smaller, early phase or pilot clinical trials, innovation is an important component and therefore preliminary data are not required. An application may demonstrate innovation not only by investigating a novel therapeutic approach for GWI, but also by studying a treatment that may have been utilized for other chronic multisymptom illnesses, but has not yet been studied in Veterans with GWI. Larger, more definitive clinical trials, including expansion of previous promising pilot trials, must include preliminary data with respect to safety in a GWI Veteran population. The requested budget must be commensurate with the phase and size of the trial proposed. Refer to Section II.D.5, Funding Restrictions for detailed funding information. New in FY18! Biorepository Contribution Option: In FY17, the GWIRP awarded infrastructure support for a Gulf War Illness Biorepository. The “Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) for GWI” has now been established for the retention and distribution of biospecimens and/or data related to GWI research. Applicants to the FY18 GWIRP are encouraged to contribute biospecimens and data to this repository network. The FY18 GWIRP Clinical Trial Award offers a nested Biorepository Contribution Option with higher levels of funding for qualified applications as described in Section II.D.5, Funding Restrictions. For the application to qualify for a higher level of funding, the Principal Investigator (PI) must submit a Biorepository Contribution Statement (see Attachment 13) providing a detailed accounting of proposed costs and a commitment to work with protocols and Standard Operating Procedures (SOPs) developed by the BBRAIN for quality assurance purposes. Applicants interested in collaborating with this network should refer to the Research Resources link (http://cdmrp.army.mil/gwirp/resources/gwirpresources) on the GWIRP website.
Federal Grant Title: | Gulf War Illness, Clinical Trial Award |
Federal Agency Name: | Dept of the Army USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-18-GWIRP-CTA |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | November 8th, 2018 |
Original Application Deadline: | November 8th, 2018 |
Posted Date: | May 1st, 2018 |
Creation Date: | May 1st, 2018 |
Archive Date: | December 8th, 2018 |
Total Program Funding: | $6,500,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 4 |
Cost Sharing or Matching: | No |
Last Updated: | May 1st, 2018 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DoD Rare Cancers, Concept Award
- • DoD Multiple Sclerosis, Early Investigator Research Award
- • DoD Rare Cancers, Idea Development Award
- • DoD Tuberous Sclerosis Complex, Clinical Translational Research Award
- • DoD Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • DoD Rare Cancers, Concept Award
- • DoD Multiple Sclerosis, Early Investigator Research Award
- • DoD Rare Cancers, Idea Development Award